The Novel Effect of Immunomodulator-Glatiramer Acetate on Epileptogenesis and Epileptic Seizures

Background/Aims: Immunological mechanisms can be triggered as a response to central nervous system insults and can lead to seizures. In this study an investigation was made to determine if glatiramer acetate (GA), an immunomodulator currently used in the treatment of multiple sclerosis, could protec...

Full description

Bibliographic Details
Main Authors: Ming-Chi Lai, Kao-Min Lin, Poh-Shiow Yeh, Sheng-Nan Wu, Chin-Wei  Huang
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2018-10-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:https://www.karger.com/Article/FullText/493965
id doaj-317c64d4c356476584f8d05a5175f5a4
record_format Article
spelling doaj-317c64d4c356476584f8d05a5175f5a42020-11-25T00:51:25ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782018-10-0150115016810.1159/000493965493965The Novel Effect of Immunomodulator-Glatiramer Acetate on Epileptogenesis and Epileptic SeizuresMing-Chi LaiKao-Min LinPoh-Shiow YehSheng-Nan WuChin-Wei  HuangBackground/Aims: Immunological mechanisms can be triggered as a response to central nervous system insults and can lead to seizures. In this study an investigation was made to determine if glatiramer acetate (GA), an immunomodulator currently used in the treatment of multiple sclerosis, could protect rats from pilocarpine-induced seizures and chronic epilepsy. Methods: Two groups of adult male Sprague-Dawley rats, experimental (GA) and control, were used in the study. The systemic IL-1α and IL-1β levels at baseline were checked as well as status epilepticus (SE), and the spontaneous recurrent seizure (SRS) stage by enzyme-linked immunosorbent assay. The GA group was given GA (150 μg/kg, ip) and the control group was given a saline injection prior to pilocarpine-induced seizures. Seizure susceptibility, severity and mortality were evaluated, using Racine seizure classification and hippocampal damage was evaluated by Nissl staining. The GA group received GA (150 μg/kg/day, ip) daily after SE, and the chronic spontaneous seizures were evaluated by long-term video recording, and mossy fiber sprouting was evaluated by Timm staining. The IL-1α and IL-1β levels were correlated with seizure activities. The TNF-α level in the hippocampus was determined at the SRS stage by immunohistochemistry. The effect of GA on ionic currents and action potentials (APs) in NG108-15 differentiated neurons was investigated using patch-clamp technology. Results: It was found that latency to severe seizures was significantly longer in the GA (p < 0.01) group, which also had SE of shorter duration and less frequent SRS (p < 0.01). GA attenuated acute hippocampal neuron loss and chronic mossy fiber sprouting in the CA3 and the SRS-reduction correlated with the reduction of IL-1α, but not with IL-1β or TNF-α levels. Mechanistically, GA reduced the peak amplitude of voltage-gated Na+ current (INa), with a negative shift in the inactivation curve of INa and reduced the amplitude of APs along with decreased firing of APs. Conclusion: GA might serve as a neuroexcitability modulator which attenuates pilocarpine-induced acute and chronic excitotoxicity. Sodium channel attenuation was partially independent of the immunomodulatory effect.https://www.karger.com/Article/FullText/493965Glatiramer acetateSeizureEpilepsySodium-channelInterleukin-1Neuron
collection DOAJ
language English
format Article
sources DOAJ
author Ming-Chi Lai
Kao-Min Lin
Poh-Shiow Yeh
Sheng-Nan Wu
Chin-Wei  Huang
spellingShingle Ming-Chi Lai
Kao-Min Lin
Poh-Shiow Yeh
Sheng-Nan Wu
Chin-Wei  Huang
The Novel Effect of Immunomodulator-Glatiramer Acetate on Epileptogenesis and Epileptic Seizures
Cellular Physiology and Biochemistry
Glatiramer acetate
Seizure
Epilepsy
Sodium-channel
Interleukin-1
Neuron
author_facet Ming-Chi Lai
Kao-Min Lin
Poh-Shiow Yeh
Sheng-Nan Wu
Chin-Wei  Huang
author_sort Ming-Chi Lai
title The Novel Effect of Immunomodulator-Glatiramer Acetate on Epileptogenesis and Epileptic Seizures
title_short The Novel Effect of Immunomodulator-Glatiramer Acetate on Epileptogenesis and Epileptic Seizures
title_full The Novel Effect of Immunomodulator-Glatiramer Acetate on Epileptogenesis and Epileptic Seizures
title_fullStr The Novel Effect of Immunomodulator-Glatiramer Acetate on Epileptogenesis and Epileptic Seizures
title_full_unstemmed The Novel Effect of Immunomodulator-Glatiramer Acetate on Epileptogenesis and Epileptic Seizures
title_sort novel effect of immunomodulator-glatiramer acetate on epileptogenesis and epileptic seizures
publisher Cell Physiol Biochem Press GmbH & Co KG
series Cellular Physiology and Biochemistry
issn 1015-8987
1421-9778
publishDate 2018-10-01
description Background/Aims: Immunological mechanisms can be triggered as a response to central nervous system insults and can lead to seizures. In this study an investigation was made to determine if glatiramer acetate (GA), an immunomodulator currently used in the treatment of multiple sclerosis, could protect rats from pilocarpine-induced seizures and chronic epilepsy. Methods: Two groups of adult male Sprague-Dawley rats, experimental (GA) and control, were used in the study. The systemic IL-1α and IL-1β levels at baseline were checked as well as status epilepticus (SE), and the spontaneous recurrent seizure (SRS) stage by enzyme-linked immunosorbent assay. The GA group was given GA (150 μg/kg, ip) and the control group was given a saline injection prior to pilocarpine-induced seizures. Seizure susceptibility, severity and mortality were evaluated, using Racine seizure classification and hippocampal damage was evaluated by Nissl staining. The GA group received GA (150 μg/kg/day, ip) daily after SE, and the chronic spontaneous seizures were evaluated by long-term video recording, and mossy fiber sprouting was evaluated by Timm staining. The IL-1α and IL-1β levels were correlated with seizure activities. The TNF-α level in the hippocampus was determined at the SRS stage by immunohistochemistry. The effect of GA on ionic currents and action potentials (APs) in NG108-15 differentiated neurons was investigated using patch-clamp technology. Results: It was found that latency to severe seizures was significantly longer in the GA (p < 0.01) group, which also had SE of shorter duration and less frequent SRS (p < 0.01). GA attenuated acute hippocampal neuron loss and chronic mossy fiber sprouting in the CA3 and the SRS-reduction correlated with the reduction of IL-1α, but not with IL-1β or TNF-α levels. Mechanistically, GA reduced the peak amplitude of voltage-gated Na+ current (INa), with a negative shift in the inactivation curve of INa and reduced the amplitude of APs along with decreased firing of APs. Conclusion: GA might serve as a neuroexcitability modulator which attenuates pilocarpine-induced acute and chronic excitotoxicity. Sodium channel attenuation was partially independent of the immunomodulatory effect.
topic Glatiramer acetate
Seizure
Epilepsy
Sodium-channel
Interleukin-1
Neuron
url https://www.karger.com/Article/FullText/493965
work_keys_str_mv AT mingchilai thenoveleffectofimmunomodulatorglatirameracetateonepileptogenesisandepilepticseizures
AT kaominlin thenoveleffectofimmunomodulatorglatirameracetateonepileptogenesisandepilepticseizures
AT pohshiowyeh thenoveleffectofimmunomodulatorglatirameracetateonepileptogenesisandepilepticseizures
AT shengnanwu thenoveleffectofimmunomodulatorglatirameracetateonepileptogenesisandepilepticseizures
AT chinweihuang thenoveleffectofimmunomodulatorglatirameracetateonepileptogenesisandepilepticseizures
AT mingchilai noveleffectofimmunomodulatorglatirameracetateonepileptogenesisandepilepticseizures
AT kaominlin noveleffectofimmunomodulatorglatirameracetateonepileptogenesisandepilepticseizures
AT pohshiowyeh noveleffectofimmunomodulatorglatirameracetateonepileptogenesisandepilepticseizures
AT shengnanwu noveleffectofimmunomodulatorglatirameracetateonepileptogenesisandepilepticseizures
AT chinweihuang noveleffectofimmunomodulatorglatirameracetateonepileptogenesisandepilepticseizures
_version_ 1725245872700129280